- Home
- CYRX vs TKNO Comparison
CYRX vs TKNO Comparison
Compare CYRX & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYRX
- TKNO
- Stock Information
- Founded
- CYRX 1999
- TKNO 1996
- Country
- CYRX United States
- TKNO United States
- Employees
- CYRX N/A
- TKNO N/A
- Industry
- CYRX Biotechnology: Pharmaceutical Preparations
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- CYRX Health Care
- TKNO Health Care
- Exchange
- CYRX Nasdaq
- TKNO Nasdaq
- Market Cap
- CYRX 365.5M
- TKNO 356.4M
- IPO Year
- CYRX N/A
- TKNO 2021
- Fundamental
- Price
- CYRX $7.27
- TKNO $4.24
- Analyst Decision
- CYRX Strong Buy
- TKNO
- Analyst Count
- CYRX 10
- TKNO 0
- Target Price
- CYRX $10.90
- TKNO N/A
- AVG Volume (30 Days)
- CYRX 432.7K
- TKNO 320.2K
- Earning Date
- CYRX 08-05-2025
- TKNO 08-07-2025
- Dividend Yield
- CYRX N/A
- TKNO N/A
- EPS Growth
- CYRX N/A
- TKNO N/A
- EPS
- CYRX N/A
- TKNO N/A
- Revenue
- CYRX $232,134,000.00
- TKNO $38,250,000.00
- Revenue This Year
- CYRX N/A
- TKNO $8.73
- Revenue Next Year
- CYRX $9.36
- TKNO $16.53
- P/E Ratio
- CYRX N/A
- TKNO N/A
- Revenue Growth
- CYRX 11.75
- TKNO 3.79
- 52 Week Low
- CYRX $4.58
- TKNO $3.31
- 52 Week High
- CYRX $9.66
- TKNO $10.37
- Technical
- Relative Strength Index (RSI)
- CYRX 48.45
- TKNO 36.34
- Support Level
- CYRX $6.70
- TKNO $5.03
- Resistance Level
- CYRX $7.89
- TKNO $5.31
- Average True Range (ATR)
- CYRX 0.42
- TKNO 0.35
- MACD
- CYRX -0.05
- TKNO 0.01
- Stochastic Oscillator
- CYRX 32.57
- TKNO 15.75
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.